(Corrects paragraph 5 in February 5 story to say 2025 Prolia sales were $4.4 billion, not $1.05 billion) Feb 5 (Reuters) - ...
In A Nutshell An existing osteoporosis medication (PTH) reduced chronic back pain in three mouse models of spinal ...
CVS Health Inc. CVS on Thursday said it is taking additional steps to lower prescription drug costs by expanding access to ...
CVS Health®   today announced new steps to further help customers expand adoption of lower-cost biosimilar medications. Effective April 1, 2026, CVS Caremark will begin offering osteoporosis ...
Eli Lilly and Company LLY will report its fourth-quarter and full-year 2025 earnings on Feb. 4, before market open. The Zacks ...
CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and ...
Don’t recognize a tablet or capsule? Our Pill Identifier helps to find the name and image of an unknown prescription or over-the-counter medication. To start, enter details like pill imprint code, ...